CN104189789A - Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis - Google Patents
Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis Download PDFInfo
- Publication number
- CN104189789A CN104189789A CN201410510154.5A CN201410510154A CN104189789A CN 104189789 A CN104189789 A CN 104189789A CN 201410510154 A CN201410510154 A CN 201410510154A CN 104189789 A CN104189789 A CN 104189789A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- rhizoma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 26
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 206010023126 Jaundice Diseases 0.000 title abstract description 14
- 230000001154 acute effect Effects 0.000 title abstract description 11
- 208000015181 infectious disease Diseases 0.000 title abstract description 4
- 230000002458 infectious effect Effects 0.000 title abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 23
- 201000010099 disease Diseases 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 210000003038 endothelium Anatomy 0.000 claims abstract description 9
- 241000756943 Codonopsis Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 241000722953 Akebia Species 0.000 claims description 5
- 235000014375 Curcuma Nutrition 0.000 claims description 5
- 241001522129 Pinellia Species 0.000 claims description 5
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004185 liver Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 8
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000748223 Alisma Species 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241001522232 Pinellia ternata Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000021028 berry Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 21
- 230000036407 pain Effects 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 19
- 230000001737 promoting effect Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 206010047700 Vomiting Diseases 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000008673 vomiting Effects 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 206010061428 decreased appetite Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000003908 liver function Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000407170 Curcuma Species 0.000 description 4
- 241000555712 Forsythia Species 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019842 Hepatomegaly Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis, and belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from the following raw materials: Chinese angelica, nutgrass galingale rhizome, cassia twig, giant knotweed, pinellia ternata, costustoot, radix codonopsitis, Indian buead, fructus amomi, akebiaquinata, atractylodes macrocephala, rhizoma atractylodis, shizandra berry, fructus forsythiae, tree peony bark, alisma, radix salviae miltiorrhizae, Chinese thorowax, white paeony root, endothelium corneum gigeriae galli, cortex phellodendri, capillary wormwood herb, dahurian patrinia herb, chinaberry fruit, curcuma aromatica and liquorice. According to the traditional Chinese medicine composition provided by the invention, after the raw materials are combined, the drug effects have synergistic effect, so that the functions of clearing heat, eliminating dampness, soothing the liver and dispersing blood stasis are achieved; the medical difficult problems that the acute jaundice type hepatitis occurs repeatedly, and the acute jaundice type hepatitis is difficult to cure are solved completely, both symptoms and root causes of the disease are cured, and the side effects are avoided.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of icterohepatitis, specifically a kind of Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis, belongs to technical field of Chinese medicines.
Background technology
Fiedeler's disease type hepatitis is a type of acute viral hepatitis, is a kind of acute infectious disease of the digestive tract being caused by hepatitis virus.Clinical manifestation take that general fatigue is unable, stifled swollen, the hepatomegaly of loss of appetite, nausea and vomiting, upper abdomen and tenderness, abnormal liver function are main manifestations.Have a medical check-up and can find percussion tenderness over hepatic region and tenderness, hepatitis b surface antigen positive, hepatitis B core antibody IgM (anti--HBcIgM) positive.In patient's blood, defecation, vomitus, all contain a large amount of hepatitis viruss, thereby have very strong infectiousness, the jaundice being in a bad way is deepened, ascites, edema of lower limbs.
The clinical treatment method for the treatment of Fiedeler's disease type hepatitis is a lot, and treatment at present mainly be take doctor trained in Western medicine as main, but existing medicine mostly takes effect slowly, and treatment time is long, and curative effect is not obvious.
Summary of the invention
The object of the invention is to overcome the deficiency that prior art exists, and a kind of Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis is provided, acute icterohepatitis is had to significant curative effect.
The technical scheme that technical solution problem of the present invention is taked is:
A kind of Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis, it is characterized in that, raw material by following weight is made: Radix Angelicae Sinensis 5-15 gram, Rhizoma Cyperi 5-15 gram, Ramulus Cinnamomi 5-15 gram, Rhizoma Polygoni Cuspidati 5-15 gram, Rhizoma Pinelliae 5-15 gram, Radix Aucklandiae 5-15 gram, Radix Codonopsis 5-15 gram, Poria 5-15 gram, Fructus Amomi 5-15 gram, Caulis Akebiae 5-15 gram, Rhizoma Atractylodis Macrocephalae 5-15 gram, Rhizoma Atractylodis 5-15 gram, Fructus Schisandrae Chinensis 5-15 gram, Fructus Forsythiae 5-15 gram, Cortex Moutan 10-20 gram, Rhizoma Alismatis 10-20 gram, Radix Salviae Miltiorrhizae 10-20 gram, Radix Bupleuri 10-20 gram, Radix Paeoniae Alba 10-20 gram, Endothelium Corneum Gigeriae Galli 15-25 gram, Cortex Phellodendri 15-25 gram, Herba Artemisiae Scopariae 20-30 gram, Herba Patriniae 5-8 gram, Fructus Toosendan 5-8 gram, Radix Curcumae 5-8 gram, Radix Glycyrrhizae 5-8 gram.
The further technical scheme of the present invention is: this kind treated the Chinese medicine composition of Fiedeler's disease type hepatitis, raw material by following weight is made: 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Cyperis, 10 grams of Ramulus Cinnamomi, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of the Rhizoma Pinelliaes, 10 grams of the Radix Aucklandiae, 10 grams of Radix Codonopsis, 10 grams, Poria, 10 grams of Fructus Amomis, 10 grams of Caulis Akebiaes, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Rhizoma Atractylodis, 10 grams of Fructus Schisandrae Chinensis, 10 grams of Fructus Forsythiaes, 15 grams of Cortex Moutans, 15 grams of Rhizoma Alismatis, 15 grams of Radix Salviae Miltiorrhizaes, 15 grams of Radix Bupleuri, 15 grams of the Radix Paeoniae Albas, 20 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Cortex Phellodendris, 25 grams of Herba Artemisiae Scopariaes, 6 grams of Herba Patriniae, 6 grams of Fructus Toosendans, 6 grams of Radix Curcumaes, 6 grams, Radix Glycyrrhizae.
Preparation and using method:
1. according to above-mentioned weight, take raw material,
2. endo-medicine raw material step being taken in is 1. placed in marmite, then adds water to and does not have raw material 2-5cm, soaks after 10-20min, is heated to 50 ℃, adds a cover insulation 20-50min; Then big fire is heated to boiling, turns little fire and decocts 30-90min, filters, and obtains filtrate one, and filtering residue stays in pot, adds water to and does not have filtering residue, continues to decoct 10-20min, filters, and obtains filtrate two;
3. filtrate one and filtrate two are merged, mix, obtain endo-medicine;
Instructions of taking: described oral medicinal herb, every day potion, every dose twice, 10 day is a course for the treatment of.
The pharmacological action of each Chinese medicine:
Radix Angelicae Sinensis: sweet, acrid, warm.Enter the heart, liver, spleen channel.Benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturizes laxation.Control menoxenia, amenorrhea stomachache ， mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; Dryness of the intestine dyschezia is heavy after bloody dysentery; Carbuncle skin ulcer is stolen, injury from falling down.
Rhizoma Cyperi: pungent micro-hardship is sweet, flat.Enter liver, tri-jiao channel.The resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation.Treating the liver discomfort in the stomach, depression of QI, breast abdomen distending pain over the hypochondrium, phlegm retention feeling of fullness, menoxenia, bleeding not during menses.
Ramulus Cinnamomi: Xin Gan, temperature.Enter bladder, the heart, lung meridian.Diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation.Control exterior syndrome due to wind-cold, shoulder back of the body podomere ache, thoracic obstruction phlegm retention, amenorrhea and mass in the abdomen.
Rhizoma Polygoni Cuspidati: hardship, cold, return liver, lung, gallbladder meridian.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, dampness removing jaundice eliminating, relieving cough and asthma.This product bitter cold is fallen and is let out, and merit is arrogated to oneself removing damp-heat from the liver and the gallbladder, again can promoting blood circulation to restore menstrual flow pain relieving.
The Rhizoma Pinelliae: dampness is through expectorant, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Control damp-phlegm cold drink, vomiting regurgitation, syncope due to accumulation of phlegm headache, dizzy sleeplessness.
The Radix Aucklandiae: gas fragrance, taste is sweet, bitter, slightly stings tongue.Warm in nature, acrid in the mouth, hardship.Promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.For heavy after breast gastral cavity distending pain, dysentery, food stagnation does not disappear, anorexia.
Radix Codonopsis: sweet, flat.Start with, meridian of Foot-TAI YIN edema caused by disorder of QI.Invigorating the spleen and replenishing QI, promotes the production of body fluid, and nourishes blood.For the empty asthenia of body of deficiency of QI in middle-JIAO, weakness of the spleen and stomach, deficiency of both QI and blood, controls fatigue and lack of strength, lung qi virtual loss.Control lack of appetite, thirsty, chronic diarrhea, proctoptosis.And the two shallow complexions of losing of QI and blood, dizzy cardiopalmus etc.
Poria: sweet light, flat.Enter the heart, spleen, lung meridian.Eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, edema distension, phlegm retention cough with dyspnea, the sound of vomiting of vomitting, has loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
Fructus Amomi: pungent, temperature.Enter spleen, stomach warp.During circulation of qi promoting is adjusted, stomach function regulating, is amusing.Control stomachache painful abdominal mass swollen, anorexia dyspepsia, dysphagic vomiting, diarrhea due to cold pathogen cold-dysentery, pregnant fetal movement.
Caulis Akebiae: hardship, cool.Enter the heart, small intestinal, urinary bladder channel.Pathogenic fire purging row water, promoting blood circulation.Control hot urination, stranguria with turbid discharge, edema, irritable feverish sensation in the chest, sore throat pharyngalgia, inflexible pain all over, women's amenorrhea, galactostasis.
The Rhizoma Atractylodis Macrocephalae: bitter sweet, temperature.Enter spleen, stomach warp.Spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea is uneasy.
Rhizoma Atractylodis: arduous, temperature.Enter spleen, stomach warp.Spleen invigorating, dampness, resolving depression, wards off dirty.Control the wet tired spleen of containing, asthenia drowsiness, gastral cavity painful abdominal mass abdominal distention, inappetence, vomiting, has loose bowels, dysentery, malaria, phlegm retention, edema, seasonal epidemic pathogens flu, anemofrigid-damp arthralgia, flaccidity of the lower limbs, nyctalopia.
Fructus Schisandrae Chinensis: acid, temperature.Enter lung, kidney channel, astringe the lung, nourishing kidney, promotes the production of body fluid, and receives antiperspirant, arresting seminal emission.Control the deficiency of the lung and breath with cough, xerostomia is done thirsty, spontaneous perspiration, night sweat, impairment caused by overstrain weakness and emaciation, emission, chronic diarrhea chronic dysentery.
Fructus Forsythiae: heat clearing away, removing toxic substances, eliminating stagnation, detumescence.Control warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula, urine stranguria with urinary obstruction; Laryngopharynx swelling and pain, rubella.
Cortex Moutan: arduous, cool.Enter the heart, liver, kidney channel.Heat clearing away, removing heat from blood, and blood, repercussive.Control the pathogenic heat attacking blood system in febrile diseases, send out speckle, infantile convulsion, tells, is defeated in battle, has blood in stool, hectic fever due to YIN-deficiency consumptive fever, and amenorrhea ， mass in the abdomen, carbuncle and ulcer, flutters damage.
Rhizoma Alismatis: sweet, cold.Enter kidney, urinary bladder channel.Diuretic, eliminating dampness by diuresis, expels the heat-evil.Control dysuria, edema distension, vomiting, dysentery, phlegm retention, beriberi, gonorrhea, hematuria.
Radix Salviae Miltiorrhizae: hardship, is slightly cold; GUIXIN, Liver Channel.Activating blood circulation to dissipate blood stasis, removing heat from blood mind calming.This product is fallen and promoting the circulation of blood, is apt to into blood system, can qualcomm meridian, change stasis, clearing away heart-fire, removing heat from blood heat, and the will of calming the nerves, tired except throbbing with fear, is usually used in obstruction of qi in the chest and cardialgia, and menstruation portion adjusts, skin infection swells and ache, insomnia and the congestion disease such as swell and ache.
Radix Bupleuri: pungent, micro-hardship, be slightly cold; Return liver, gallbladder meridian.Induce sweat and bring down a fever, soothing liver-QI for relieving depression, elevate a turnable ladder yang-energy.This product is dredged and to be reached thoroughly kindly, is longer than and discongests stagnant heat in the liver and gall, again can depressed liver-energy dispersing and QI regulating, and be pain over the hypochondriac region key medicine due to treatment stagnant heat in the liver and gall, stagnation of QI due to depression of the liver.Pharmacological research confirms: the effects such as Radix Bupleuri has stronger antipyretic, antiinflammatory, antibacterial, antiviral, protects the liver, function of gallbladder promoting, calmness, analgesia.
The Radix Paeoniae Alba: picric acid is cool.Enter liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant. control the breast abdomen pain over the hypochondriac region, spontaneous sweating, fever due to yin deficiency.
Endothelium Corneum Gigeriae Galli: removing food stagnancy is stagnant, strengthening the spleen and stomach.Control food stagnation distension, vomiting regurgitation, dysentery, infantile malnutrition, quenches one's thirst, incontinence of urine, sore throat tonsillitis, ulcerative gingivitis aphtha.
Cortex Phellodendri: hardship, cold.Enter kidney, urinary bladder channel.Heat clearing away, dampness, pathogenic fire purging is except steaming, detoxification sore treatment.For damp-heat dysentery, jaundice, leukorrhagia, pyretic stranguria, osteopyrexia and fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus.Pharmacological research shows, Cortex Phellodendri decocting liquid has inhibitory action to gram-positive cocci and Gram-negative coccus in vitro, has resisting pathogenic microbes effect simultaneously, and can suppress the contractile response that caused by acetylcholine.
Herba Artemisiae Scopariae: cold nature, acrid in the mouth, hardship.Clearing away damp-heat, jaundice eliminating subcutaneous ulcer.For jaundice oliguria, eczema pruritus, infectious jaundice type hepatitis.
Herba Patriniae: nature and flavor are cool in nature, acrid in the mouth, hardship.Heat-clearing and toxic substances removing, removing blood stasis and expelling pus.For appendicitis, dysentery, enteritis, hepatitis, eye conjunctivitis, postnatal blood stasis stomachache, carbuncle furuncle.
Fructus Toosendan: hardship, cold, return liver, pericardium, small intestinal, urinary bladder channel.Circulation of qi promoting, parasite killing, pain relieving.This product bitter cold is fallen and is let out, and can be soothing the liver strongly fragrant, clearing away liver-fire, except damp and hot, promoting the circulation of QI to relieve pain is widely used in gastral cavity abdomen hypochondriac pain due to stagnation of QI due to depression of the liver, hernia and abdominal pain due to worm stagnation.
Radix Curcumae: arduous, cool.Enter the heart, lung, Liver Channel.Promoting QI circulation for relieving depression, removing heat from blood removing blood stasis with potent drugs, controls all pains of breast abdomen side of body rib, loses the heart demented, calentura coma.Spit blood, jaundice.
Radix Glycyrrhizae: sweet, flat.GUIXIN, lung, spleen, stomach warp.Invigorating the spleen and replenishing QI, grows and coughs lung moistening, emergency removing toxic substances, mediation hundred medicines.Cure mainly laryngopharynx swelling and pain, cellulitis skin infection, gastrointestinal ulceration and solution poison of drug, alimentary toxicosis etc.
The traditional Chinese medical science thinks that acute icterohepatitis principal contradiction is retention and fumigation of damp-heat inside the body, and liver and gall are impaired, and its disease belongs to acute jaundice category, damp and hotly enters blood, and stasis blocking blood vessels, accumulate the raw expectorant of poison, stifling skin and the subcutaneous ulcer of turning to be yellow.After we's drug regimen, drug effect has synergism, plays the effect of eliminating damp-heat, soothing the liver blood stasis dispelling.Thoroughly solved acute icterohepatitis again and again, cureless difficult medical problem, reach treating both the principal and secondary aspects of a disease, without any side effects.
Below in conjunction with clinical data and model case, beneficial effect of the present invention is further illustrated.
One, clinical observation
1, clinical data: select Fiedeler's disease type hepatitis 58 examples, male 30 examples, female's 28 examples, 10～14 years old age, 21 examples, 21～30 years old 15 example, 31～43 years old 22 example.All 58 cases are divided into two groups at random, treatment group 29 people, matched group 29 people.
2, diagnostic criteria:
(1) there is close contact history with acute hepatitis patient;
(2) fatigue and weak, lack of appetite poor appetite, feels sick, vomits, detests greasy, distension and fullness in the abdomen, hepatalgia (children's's readme stomachache), large dry stool, urine yellow skin as strong tea;
(3) skin, yellow sclera be as Fructus Citri tangerinae color, red tongue, yellow and greasy fur;
(4) percussion tenderness over hepatic region, hepatomegaly, quality is soft, and indivedual patients have spleen silght enlargement;
(5) laboratory examination serum bilirubin obviously increases, more than transaminase GPT150U.More than AST glutamic oxaloacetic transaminase, GOT 75.20U/L.HBsAg (hepatitis B surface antigen) positive.
3, Therapeutic Method:
(1), treatment group: take Chinese medicine for oral administration of the present invention, be decocted in water for oral dose, every day potion, every dose twice, 10 day is a course for the treatment of.(2), matched group: 10% glucose 500ml, potenlin 20～40ml, adenosine triphosphate 20～40mg, coenzyme A 100～200U, inosine 0.4g, vitamin 1.0～2.0g, mattress Cape jasmine Huang 10～40ml, intravenous drip.10 days be a course for the treatment of every day 1 time.
4, efficacy assessment standard:
Cure: subjective symptoms disappears, it is normal that clinical assay indices recovers;
Effective: subjective symptoms disappears, and clinical assay indices is clearly better;
Effective: subjective symptoms takes a turn for the better, clinical assay indices takes a turn for the better;
Invalid: symptom and sign are all unchanged or increase the weight of.
5, therapeutic outcome:
In Table 1.
Table 1 therapeutic outcome data
| Group | Number | Cure | Effective | Effectively | Invalid | Total effective rate (%) |
| Treatment group | 29 | 23 | 3 | 2 | 1 | 96.6 |
| Matched group | 29 | 15 | 3 | 2 | 9 | 69 |
Result: show by upper table treatment situation, treatment group total effective rate is 96.6%, and matched group total effective rate is 69%, and treatment group curative effect is obviously better than matched group.
Two, model case
Case 1, Zou so-and-so, female, 17 years old.Unable, the nauseating nausea of patient's anorexia, mouthful sticky bitter taste, right flank portion dull pain discomfort, to hospital, through liver function, chemically examine, result shows acute icterohepatitisshock, and through taking Drug therapy of the present invention after 3 courses for the treatment of, xanthochromia is clearly better, symptom also has and alleviates, continue to take medicine a course for the treatment of, all clinical symptom disappearance, blood test liver function is normal, patient disease recovery from illness, follows up a case by regular visits to and within 1 year, has no recurrence.
Case 2, Liu so-and-so, female, 45 years old.Patient started to occur lassitude before half a year, dizziness, and fatigue and weak, two lower limbs are micro-swollen, poor sleeping quality, the vexed pain in hepatic region.Through hospital diagnosis, be treatment Fiedeler's disease type hepatitis.Through taking Drug therapy of the present invention after 2 courses for the treatment of, spirit takes a turn for the better, two lower limb detumescences, the quality of sleeping increases, continue medication treatment after 3 courses for the treatment of liver function normal, liver spleen is all contracted to normal range, blood test liver function is normal, and patient disease recovery from illness, follows up a case by regular visits to and within 1 year, have no recurrence.
Case 3, fights so-and-so, man, 21 years old.Patient's prolapse sense more than a year inappetence, the vexed pain in hepatic region, nausea and vomiting, abdominal distention are suffered from diarrhoea, have a fever weak, in chemical examination transaminase 270 units of hospital, through hospital diagnosis, are Fiedeler's disease type hepatitis.1 course for the treatment of of Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis through taking the present invention, does not have a pain in hepatic region, and appetite is gradually good.Continue by 2 courses for the treatment of of former side's medication, abdominal distention diarrhoea, weak, jaundice recover normal, transaminase 145 units.1 course for the treatment of of after treatment, further consultation checks liver function, and full recovery is normal, and subjective symptoms all disappears.Follow up a case by regular visits to no abnormality seen 1 year.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine composition for Fiedeler's disease type hepatitis, by the raw material of following weight, made: 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Cyperis, 10 grams of Ramulus Cinnamomi, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of the Rhizoma Pinelliaes, 10 grams of the Radix Aucklandiae, 10 grams of Radix Codonopsis, 10 grams, Poria, 10 grams of Fructus Amomis, 10 grams of Caulis Akebiaes, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Rhizoma Atractylodis, 10 grams of Fructus Schisandrae Chinensis, 10 grams of Fructus Forsythiaes, 15 grams of Cortex Moutans, 15 grams of Rhizoma Alismatis, 15 grams of Radix Salviae Miltiorrhizaes, 15 grams of Radix Bupleuri, 15 grams of the Radix Paeoniae Albas, 20 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Cortex Phellodendris, 25 grams of Herba Artemisiae Scopariaes, 6 grams of Herba Patriniae, 6 grams of Fructus Toosendans, 6 grams of Radix Curcumaes, 6 grams, Radix Glycyrrhizae.
Preparation and using method:
1. according to above-mentioned weight, take raw material,
2. endo-medicine raw material step being taken in is 1. placed in marmite, then adds water to and does not have raw material 2-5cm, soaks after 10-20min, is heated to 50 ℃, adds a cover insulation 20-50min; Then big fire is heated to boiling, turns little fire and decocts 30-90min, filters, and obtains filtrate one, and filtering residue stays in pot, adds water to and does not have filtering residue, continues to decoct 10-20min, filters, and obtains filtrate two;
3. filtrate one and filtrate two are merged, mix, obtain endo-medicine;
Instructions of taking: described oral medicinal herb, every day potion, every dose twice, 10 day is a course for the treatment of.
Embodiment 2:
Treat a Chinese medicine composition for Fiedeler's disease type hepatitis, by the raw material of following weight, made: 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Cyperis, 10 grams of Ramulus Cinnamomi, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of the Rhizoma Pinelliaes, 10 grams of the Radix Aucklandiae, 10 grams of Radix Codonopsis, 10 grams, Poria, 10 grams of Fructus Amomis, 15 grams of Caulis Akebiaes, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 12 grams of Rhizoma Atractylodis, 12 grams of Fructus Schisandrae Chinensis, 12 grams of Fructus Forsythiaes, 15 grams of Cortex Moutans, 15 grams of Rhizoma Alismatis, 15 grams of Radix Salviae Miltiorrhizaes, 15 grams of Radix Bupleuri, 15 grams of the Radix Paeoniae Albas, 20 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Cortex Phellodendris, 25 grams of Herba Artemisiae Scopariaes, 6 grams of Herba Patriniae, 6 grams of Fructus Toosendans, 6 grams of Radix Curcumaes, 6 grams, Radix Glycyrrhizae.
Preparation and using method: with example 1.
Embodiment 3:
Treat a Chinese medicine composition for Fiedeler's disease type hepatitis, by the raw material of following weight, made: 12 grams of Radix Angelicae Sinensis, 12 grams of Rhizoma Cyperis, 12 grams of Ramulus Cinnamomi, 10 grams of Rhizoma Polygoni Cuspidati, 12 grams of the Rhizoma Pinelliaes, 10 grams of the Radix Aucklandiae, 10 grams of Radix Codonopsis, 10 grams, Poria, 10 grams of Fructus Amomis, 12 grams of Caulis Akebiaes, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Rhizoma Atractylodis, 10 grams of Fructus Schisandrae Chinensis, 10 grams of Fructus Forsythiaes, 15 grams of Cortex Moutans, 15 grams of Rhizoma Alismatis, 15 grams of Radix Salviae Miltiorrhizaes, 15 grams of Radix Bupleuri, 15 grams of the Radix Paeoniae Albas, 20 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Cortex Phellodendris, 25 grams of Herba Artemisiae Scopariaes, 8 grams of Herba Patriniae, 8 grams of Fructus Toosendans, 6 grams of Radix Curcumaes, 6 grams, Radix Glycyrrhizae.
Preparation and using method: with example 1.
Claims (2)
1. a Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis, it is characterized in that, raw material by following weight is made: Radix Angelicae Sinensis 5-15 gram, Rhizoma Cyperi 5-15 gram, Ramulus Cinnamomi 5-15 gram, Rhizoma Polygoni Cuspidati 5-15 gram, Rhizoma Pinelliae 5-15 gram, Radix Aucklandiae 5-15 gram, Radix Codonopsis 5-15 gram, Poria 5-15 gram, Fructus Amomi 5-15 gram, Caulis Akebiae 5-15 gram, Rhizoma Atractylodis Macrocephalae 5-15 gram, Rhizoma Atractylodis 5-15 gram, Fructus Schisandrae Chinensis 5-15 gram, Fructus Forsythiae 5-15 gram, Cortex Moutan 10-20 gram, Rhizoma Alismatis 10-20 gram, Radix Salviae Miltiorrhizae 10-20 gram, Radix Bupleuri 10-20 gram, Radix Paeoniae Alba 10-20 gram, Endothelium Corneum Gigeriae Galli 15-25 gram, Cortex Phellodendri 15-25 gram, Herba Artemisiae Scopariae 20-30 gram, Herba Patriniae 5-8 gram, Fructus Toosendan 5-8 gram, Radix Curcumae 5-8 gram, Radix Glycyrrhizae 5-8 gram.
2. a kind of Chinese medicine composition for the treatment of Fiedeler's disease type hepatitis according to claim 1, it is characterized in that, raw material by following weight is made: 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Cyperis, 10 grams of Ramulus Cinnamomi, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of the Rhizoma Pinelliaes, 10 grams of the Radix Aucklandiae, 10 grams of Radix Codonopsis, 10 grams, Poria, 10 grams of Fructus Amomis, 10 grams of Caulis Akebiaes, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Rhizoma Atractylodis, 10 grams of Fructus Schisandrae Chinensis, 10 grams of Fructus Forsythiaes, 15 grams of Cortex Moutans, 15 grams of Rhizoma Alismatis, 15 grams of Radix Salviae Miltiorrhizaes, 15 grams of Radix Bupleuri, 15 grams of the Radix Paeoniae Albas, 20 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Cortex Phellodendris, 25 grams of Herba Artemisiae Scopariaes, 6 grams of Herba Patriniae, 6 grams of Fructus Toosendans, 6 grams of Radix Curcumaes, 6 grams, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410510154.5A CN104189789A (en) | 2014-09-28 | 2014-09-28 | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410510154.5A CN104189789A (en) | 2014-09-28 | 2014-09-28 | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104189789A true CN104189789A (en) | 2014-12-10 |
Family
ID=52075260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410510154.5A Pending CN104189789A (en) | 2014-09-28 | 2014-09-28 | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104189789A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104689137A (en) * | 2015-04-03 | 2015-06-10 | 臧海阳 | Traditional Chinese medicine composition for treating acute icteric hepatitis |
| CN104826035A (en) * | 2015-06-04 | 2015-08-12 | 王星月 | Traditional Chinese medicine decoction for treating acute icteric hepatitis |
| CN104857491A (en) * | 2015-06-04 | 2015-08-26 | 王星月 | Traditional Chinese medicine for treating acute icteric hepatitis |
| CN105168974A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine composition for treating jaundice hepatitis |
| CN106237263A (en) * | 2016-09-23 | 2016-12-21 | 辽宁润生康泰生物医药科技有限公司 | A kind of treat acute icterohepatitis and Chinese medicine composition that chronic hepatitis acute onset raises with bilirubin |
| CN107496621A (en) * | 2017-10-11 | 2017-12-22 | 王继显 | One kind treats acute icteric hepatitis medicine composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101168029A (en) * | 2007-11-06 | 2008-04-30 | 郭太平 | Method for manufacturing liver-smoothing, qi-regulating and detoxification capsule |
| CN101417116A (en) * | 2008-12-10 | 2009-04-29 | 韩杰 | Decoction for treating urgent hepatitis with jaundice |
| CN101979070A (en) * | 2010-10-27 | 2011-02-23 | 苏桂华 | Chinese medicament for treating hepatitis B |
-
2014
- 2014-09-28 CN CN201410510154.5A patent/CN104189789A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101168029A (en) * | 2007-11-06 | 2008-04-30 | 郭太平 | Method for manufacturing liver-smoothing, qi-regulating and detoxification capsule |
| CN101417116A (en) * | 2008-12-10 | 2009-04-29 | 韩杰 | Decoction for treating urgent hepatitis with jaundice |
| CN101979070A (en) * | 2010-10-27 | 2011-02-23 | 苏桂华 | Chinese medicament for treating hepatitis B |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104689137A (en) * | 2015-04-03 | 2015-06-10 | 臧海阳 | Traditional Chinese medicine composition for treating acute icteric hepatitis |
| CN104826035A (en) * | 2015-06-04 | 2015-08-12 | 王星月 | Traditional Chinese medicine decoction for treating acute icteric hepatitis |
| CN104857491A (en) * | 2015-06-04 | 2015-08-26 | 王星月 | Traditional Chinese medicine for treating acute icteric hepatitis |
| CN105168974A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine composition for treating jaundice hepatitis |
| CN106237263A (en) * | 2016-09-23 | 2016-12-21 | 辽宁润生康泰生物医药科技有限公司 | A kind of treat acute icterohepatitis and Chinese medicine composition that chronic hepatitis acute onset raises with bilirubin |
| CN107496621A (en) * | 2017-10-11 | 2017-12-22 | 王继显 | One kind treats acute icteric hepatitis medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189789A (en) | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis | |
| CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN103736072B (en) | Medicine of a kind for the treatment of of allergic rhinitis and preparation method thereof | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
| CN102526670B (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN104258289A (en) | Traditional Chinese medicine for treating enteritis | |
| CN104524287A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicinal composition | |
| CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
| CN104784415A (en) | Traditional Chinese medicine pill for treating acute eruptive infectious disease and preparation method | |
| CN106362111A (en) | Pharmaceutical composition for improving phlegm-dampness constitution, medicine brick and preparation method of medicine brick | |
| CN103041255B (en) | Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children | |
| CN104225553A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
| CN104771578A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN104324350A (en) | Traditional Chinese medicine composition for chronic colitis and preparation method of traditional Chinese medicine composition | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN104888178A (en) | Infantile diarrhea treatment traditional Chinese medicine | |
| CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
| CN106692858A (en) | Medicine for treating threatened abortion and preparation method of medicine | |
| CN105327295A (en) | Capsules for treating hepatitis and preparing method thereof | |
| CN103356970A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| CN105709176A (en) | Traditional Chinese medicine composition for treating heart blood stasis type palpitation and preparation method thereof | |
| CN105267895A (en) | Medicine for treating bovine postpartum blood stasis type placenta retension and preparing method thereof | |
| CN104306943A (en) | Traditional Chinese medicine combination for curing hyperlipidemia | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141210 |
|
| RJ01 | Rejection of invention patent application after publication |